Debiopharm’s investment portfolio company BC Platforms Platforms is providing its discovery and research platform to the UK’s iDx-Lung research project. This project is aimed at testing the best way of detecting lung cancers at an early stage when they can still be cured. The project is being run by a consortium of academic and industrial partners led by the Universities of Southampton and Leeds. BC Platforms technology will allow a harmonisation and analysis of the results from multiple tests that have never before been used in combination.
